Pfizer Consumer Healthcare records 2% rise

3 November 2016 - Deborah Wilkes

Archived

Worldwide sales at Pfizer Consumer Healthcare increased by 2% on an operational basis to US$798 million in the third quarter of 2016. The 2% operational rise follows sales growth of 7% for Consumer Healthcare during the first half of 2016.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: